B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction　― Relevance to Age-Related Left Ventricular Modeling in Japanese ―

Geriatric Nutritional Risk Index Predicts Cardiovascular Events in Patients at Risk for Heart Failure

“…characteristics are by clinical and echocardiographic findings as follows: prior MI, cardiomyopathy, valvular heart disease, reduced left ventricular ejection fraction (LVEF, 40%), 14 enlarged LV end-diastolic diameter (>55 mm), 18 or LV mass index >115 g/m 2 in men or >95 g/m 2 in women 19. Valvular heart disease was specifically defined as severe aortic or mitral valvular disease using echocardiography.…”

Heart failure with preserved ejection fraction: A growing global epidemic

“…BNP levels of patients with HFpEF may be lower than those of patients with HFrEF because there is less end-diastolic wall stress in HFpEF. 12,13 The BNP levels may also be normal in some patients with HFpEF, especially when patients are symptom-free. 13…”

Assessment of successful percutaneous mitral commissurotomy by MRproANP and sCD146

“…The use of natriuretic peptides has become widespread in cardiology, with brain natriuretic peptide (BNP) and Nterminal pro-B-type natriuretic peptide (NT-proBNP) used daily as markers of heart failure [1][2][3]. However, these two biomarkers remain imperfect for the diagnosis of pulmonary and systemic congestion [4][5][6]. Therefore, combining BNP/NT-proBNP with other biomarkers could help to improve their diagnostic value.…”